Patients with advanced cancer want and need to partner with their care team to make treatment decisions that reflect their own values and align with what matters most. “Serious illness conversations” include two equally important parts: clinicians sharing information on prognosis and treatment options, and patients and their loved ones sharing their values and preferences. Despite professional guidelines recommending early serious illness conversations for all patients with advanced cancer, many times these conversations occur, unfortunately, late or not at all.
As the first part of a larger initiative across Dartmouth Cancer Center, a broad team of clinician-researchers, clinical partners, data scientists and even a patient partner have implemented a quality improvement project that was able to increase the occurrence and documentation of these important conversations in two disease-specific medical oncology clinics. Over the 18-month study period, the teams increased their baseline documentation rate from 0% to 70%, or 43 of 63 eligible patients.
Results of the project, “Interdisciplinary Approach and Patient/Family Partners to Improve Serious Illness Conversations in Outpatient Oncology,” are newly published in JCO Oncology Practice, an American Society of Clinical Oncology journal.
“We partnered with our colleagues in Palliative Care, who provided an evidence-based training program to increase our knowledge, skills and comfort in leading serious illness conversations,” says lead author Garrett T. Wasp, MD, a medical oncologist in Dartmouth Cancer Center’s Head & Neck Cancer Program.
The group identified four drivers for their success: standardized work, an engaged interdisciplinary team, engaged patients and families, and system-level support. With the help of Dartmouth Health’s technology team, clinicians succeeded in documenting serious illness conversations in a standardized, one-page format that was easily accessible in the electronic medical record. The work also inspired creation of clinician-facing tools that allow for automated tracking and reporting of serious illness conversations.
The Serious Illness Conversation Model of Care is one intervention in the Promise Partnership Learning Health System: a joint venture between Dartmouth Cancer Center, The Dartmouth Institute for Health Policy & Clinical Practice and Dartmouth Health. Co-author and palliative care physician Amelia M. Cullinan, MD, joined by a team of skilled communication coaches, has spread the intervention to three additional clinical oncology groups, with two more onboarding in summer of 2022.
“These partnerships have led to insights into strategies that both individuals and health systems can use to enhance communication and decision-making for all serious illnesses, not just cancer,” says Wasp. “More effective patient–clinician communication will lead to better adherence to professional guidelines and should produce care that is more patient-centered.”
More publications and presentations at national meetings of this and future work are planned, including using patient-reported outcomes to help better access the impact.
Garrett T. Wasp, MD, is a medical oncologist in Dartmouth Cancer Center’s Head & Neck Cancer Program, Assistant Professor of Medicine at Dartmouth’s Geisel School of Medicine and Dartmouth Cancer Faculty Fellow. His research interests include communication, decision making and emotion regulation. His long term goal is to develop and test communication tools that improve how patients with cancer, their loved ones, and their healthcare providers come together to make important medical decisions. @WaspGarrett
About Dartmouth Cancer Center
Dartmouth Cancer Center combines the advanced cancer research at the Geisel School of Medicine at Dartmouth, with award-winning, personalized, and compassionate patient-centered cancer care based at the Norris Cotton Cancer Care Pavilion at Dartmouth Hitchcock Medical Center. With 14 locations around New Hampshire and Vermont, Dartmouth Cancer Center is one of only 52 National Cancer Institute-designated Comprehensive Cancer Centers. Each year the Dartmouth Cancer Center schedules 74,000 appointments seeing more than 4,500 newly diagnosed patients, and currently offers patients more than 240 active clinical trials. Celebrating its 50th anniversary in 2022, Dartmouth Cancer Center remains committed to excellence, outreach and education. We strive to prevent and cure cancer, enhance survivorship and to promote cancer health equity through pioneering interdisciplinary research and collaborations. Learn more at http://cancer.dartmouth.edu.